MedTrace Logo

Patients´ Mental and Physical Health After Covid-19 Treated in ICU in Sweden

NCT06042790 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2023-09-21

No results posted yet for this study

Summary

Covid-19 is a disease where both clinical experience and thus knowledge about the long-term effects of the disease are currently sparse. However, current follow-up results indicate a more pronounced cognitive and respiratory impairment than previously seen in a normal ICU population. As we know that the prevalence of impairments in neurocognitive and Health Related Quality of Life (HRQoL) is increased in a majority of ICU patients, it would be of benefit to gain knowledge about the impact on the recovery trajectory for patients treated for Covid-19, and to increase the understanding of which factors that affect the HRQoL and recovery and in what way these differs between patients treated in ICU for Covid-19 and other causes respectively. This can contribute to better structures for follow-up and possibility to individualisation that better address which patients are in risk for decreased HRQoL and where benefit for the patient, health care and social economic can be achieved.

Conditions

  • Quality of Life
  • Intensive Care Unit Syndrome

Sponsors & Collaborators

  • Swedish Intensive Care Registry

    lead OTHER

Principal Investigators

  • Sten Walther, PhD · Linkoeping University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-08-08
Completion
2023-10-08

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06042790 on ClinicalTrials.gov